Clinical Trial

A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if the combination of cemiplimab and fianlimab can improve outcomes compared to cemiplimab alone in adults with Human Papillomavirus Positive HPV-positive head and neck cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-14.
Trial Details
NCT Number NCT07346196
Lead Sponsor University of Chicago
Conditions Squamous Cell Carcinoma
Enrollment 90 participants
Start Date 2027-02-07
Primary Completion 2031-08-22 (estimated)
Study Completion 2031-08-22 (estimated)
Updated on ClinicalTrials.gov 2026-01-20